We wait to see who will become the next drug king in the GLP-1 race.

Merck exercised its option to co-develop and commercialize mRNA-4157/V940 with Moderna for adjuvant treatment in high-risk melanoma patients.

Adeno-associated virus (AAV) is reckoned as one of the most propitious vectors for gene research and therapy. It is recommended to use the Patsnap Bio sequence database to extract sequences analogous to definite AAV sequences and examine new AAV data from sources accessible to the public, thereby providing a catalyst for advanced AAV research.

Synapse is a free drug intelligence database that streamlines research and enhances decision-making for pharmaceutical professionals. With extensive coverage of drugs, targets, and diseases, it provides valuable insights in emerging technology trends and competitive landscapes. Synapse supports partnership and investment decisions with detailed drug pipeline and investment history information.

A recent study published in journal Aging has shed light on the potential anti-aging effects of zoledronic acid, a commonly prescribed bisphosphonate.

During the process of antibody sequence retrieval, it is often necessary to align multiple antibody sequences within the same series for comprehensive research analysis. It is recommended to use the online sequence alignment feature of the BioSequence Database provided by Patsnap Bio.

Moderna's RSV vaccine based on mRNA technology is also expected to be approved soon.

Scientists from the University of Oxford, University of Cambridge, and The Pirbright Institute in the UK have discovered a potential new treatment approach for poxviruses like monkeypox and smallpox viruses.

Relaxin Family Peptide Receptor 1 (RXFP1) is the receptor of relaxin-2, and relaxin-2 is an important regulator of reproduction and cardiovascular physiology.

Interleukin-2 (IL-2) in particular has undergone extensive engineering attempts to generate IL-2 variants with selective activities.

METTL3 is an RNA methyltransferase that catalyzes the methylation of RNA at N6-adenosine, making it a key player in this process.

Researchers have made significant progress in understanding the role of NLRP3 signaling in the aging process of podocytes, a type of kidney cell.